MAYNF (Mayne Pharma Group) Inventory Turnover: 1.51 (As of Dec. 2025)

What is Mayne Pharma Group Inventory Turnover?

Mayne Pharma Group MAYNF 48 Inventory Turnover is 1.51 as of Dec. 2025. GuruFocus rates MAYNF with a GF Score™ of 48/100 and a GF Value™ of $3.87 (Possible Value Trap). The stock has 3 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Mayne Pharma Group's Cost of Goods Sold for the six months ended in Dec. 2025 was $48.8 Mil. Mayne Pharma Group's Average Total Inventories for the quarter that ended in Dec. 2025 was $32.2 Mil. Mayne Pharma Group's Inventory Turnover for the quarter that ended in Dec. 2025 was 1.51.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Mayne Pharma Group's Days Inventory for the six months ended in Dec. 2025 was 120.49.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Mayne Pharma Group's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.23.

Mayne Pharma Group (OTCPK:MAYNF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Mayne Pharma Group's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	32.238	/	48.831	*	365 / 2
	=	120.49

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Mayne Pharma Group's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	32.238	/	139.092
	=	0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Mayne Pharma Group Inventory Turnover Related Terms

Mayne Pharma Group Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Mayne Pharma Group's Inventory Turnover can be seen below:

Mayne Pharma Group Inventory Turnover Chart

Mayne Pharma Group Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Inventory Turnover

Get a 7-Day Free Trial

2.19

2.30

1.02

2.14

2.54

Mayne Pharma Group Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Inventory Turnover	Get a 7-Day Free Trial															0.94	1.05	1.18	1.43	1.51

48GF Score

Mayne Pharma Group Ltd MAYNF

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Mayne Pharma Group Inventory Turnover Calculation

Mayne Pharma Group's Inventory Turnover for the fiscal year that ended in Jun. 2025 is calculated as

	Inventory Turnover (A: Jun. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Jun. 2025 )	/ (	(Total Inventories (A: Jun. 2024 )	+	Total Inventories (A: Jun. 2025 ))	/	count )
=	104.701	/ (	(49.554	+	32.917)	/	2 )
=	104.701	/	41.2355
=	2.54

Mayne Pharma Group's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

	Inventory Turnover (Q: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2025 )	/ (	(Total Inventories (Q: Jun. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )
=	48.831	/ (	(32.917	+	31.559)	/	2 )
=	48.831	/	32.238
=	1.51

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 1.51 mean?

Mayne Pharma Group (MAYNF) has a Inventory Turnover of 1.51 as of Dec. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Mayne Pharma Group and its competitors.

Is Mayne Pharma Group's Inventory Turnover too high?

Mayne Pharma Group's current Inventory Turnover is 1.51. Overall, Mayne Pharma Group has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Mayne Pharma Group's Inventory Turnover compare to MCK and CAH?

Mayne Pharma Group's Inventory Turnover of 1.51 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Medical Distribution company?

A good Inventory Turnover depends on the Medical Distribution industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Mayne Pharma Group and its competitors. Mayne Pharma Group's current Inventory Turnover is 1.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Mayne Pharma Group stock overvalued right now?

Based on GuruFocus' analysis, Mayne Pharma Group (MAYNF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.87, compared to a current price of $1.65 — trading 57.4% below its estimated fair value. The current Inventory Turnover is 1.51. Mayne Pharma Group's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Mayne Pharma Group (MAYNF), the current Inventory Turnover is 1.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mayne Pharma Group (MAYNF) Overvalued in 2026?

Based on GuruFocus' analysis, Mayne Pharma Group stock appears to be undervalued. The current stock price of $1.65 is trading 57.4% below its estimated GF Value™ of $3.87. GuruFocus considers Mayne Pharma Group to be Possible Value Trap.

Key valuation signals for MAYNF:

Inventory Turnover: 1.51
GF Value™: $3.87 vs. price of $1.65 (57.4% below fair value)
GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the MAYNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mayne Pharma Group Business Description

Industry Healthcare Medical Distribution

Comparable Companies ASX:PGC ASX:CYC MCK CAH COR ASX:SIG HSIC SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998 TSE:7459 OSTO:ASKER MIL:AMP SHSE:600511 IST:SELEC NZSE:EBO TSE:2784 SHSE:600739

Other Exchanges MYX:Australia

Address 1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106

Website https://www.maynepharma.com

Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.

48GF Score

Get the complete analysis for MAYNF

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.65

Price

$3.87

GF Value

View MAYNF Analysis

See Inventory Turnover data for all stocks →